908 Devices stock analysis
Want to see MASS full AI Analyst Report?
908 Devices (MASS) Stock Price & Analysis
MASS Stock Chart & Stats
- Day’s Range
- $9.14 - $9.68
- 52-Week Range
- $5.03 - $13.35
- Previous Close
- $9.74
- Volume
- N/A
- Average Volume (3M)
- 387.65K
- Market Cap
- $405.01M
- Enterprise Value
- $411.40M
- Total Cash (Recent Filing)
- $99.12M
- Total Debt (Recent Filing)
- $5.05M
- Price to Earnings (P/E)
- ―
- Beta
- 1.21
- Next Earnings
- Mar 09, 2027 (Est.)
- EPS Estimate
- -0.1
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Raised Revenue Outlook
The raised outlook indicates strengthening demand across the company’s detection platforms and provides a visible near-term growth path. Expected expansion in handheld and service revenue, together with multiple product catalysts, can improve operating leverage if execution remains consistent.
Growing Installed Base And Recurring Revenue
A larger installed base creates opportunities for subscriptions, connected services, and repeat customer engagement beyond the initial device sale. The recurring-revenue strategy can make revenue more durable over time and strengthen customer retention as cloud services expand across the portfolio.
Strong Liquidity And Low Leverage
Substantial liquidity and no debt provide financial flexibility to fund product launches, international expansion, and operating investments without immediate refinancing pressure. This balance-sheet strength also gives the company greater capacity to absorb execution variability while pursuing growth.
Bears Say
Persistent Unprofitability
Although losses improved year over year, the company has not yet converted revenue growth and roughly 50% gross margins into sustainable earnings. Continued losses can constrain internal investment capacity and leave results dependent on achieving further scale and disciplined expense management.
Customer Concentration
A large share of quarterly revenue from two customers increases the potential impact of order timing, procurement decisions, or delayed funding on reported results. This concentration can make revenue less predictable and complicate efforts to sustain growth across future periods.
Expense And Margin Pressure
Higher operating expenses and a modestly lower gross margin reduce the benefit of revenue growth and slow progress toward breakeven. If international mix or NIRLab costs continue to pressure profitability, the company may need stronger volume gains to achieve its targeted EBITDA improvement.
908 Devices News
908 Devices Earns Buy Rating as Strong Q2 Results, Raised Outlook, and Growing Recurring Revenue Signal Durable Multi-Product Demand
TD Cowen analyst Brendan Smith has maintained their bullish stance on MASS stock, giving a Buy rating yesterday. Brendan Smith has given his Buy rating due to a combination of
MASS FAQ
What was 908 Devices’s price range in the past 12 months?
What is 908 Devices’s market cap?
When is 908 Devices’s upcoming earnings report date?
How were 908 Devices’s earnings last quarter?
Is 908 Devices overvalued?
Does 908 Devices pay dividends?
What is 908 Devices’s EPS estimate?
How many shares outstanding does 908 Devices have?
What happened to 908 Devices’s price movement after its last earnings report?
Which hedge fund is a major shareholder of 908 Devices?
What is the TipRanks Smart Score and how is it calculated?
908 Devices Stock Smart Score
Company Description
908 Devices
908 Devices Inc. provides purpose-built handheld mass spectrometry and fourier transform infrared (FTIR) devices for use in vital health and safety applications. The company’s products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; XplorIR, a handheld device that uses FTIR spectroscopy to identify, quantify, and track gases and vapors; ThreatID, a portable FTIR device that rapidly detects and identifies approximately 28,000 unknown gas, vapor, powder, and liquid chemical hazards; ProtectIR, a handheld FTIR device that can identify approximately 23,000 solid and liquid chemical hazards; and VipIR, a handheld 3-in-1 analyzer that integrates FTIR, Raman spectroscopy, and smart spectral processing (SSP), a proprietary algorithm, to provide a single result from just one sample. It operates in the United States, Europe, the Middle East, Africa, the Asia Pacific, and rest of Americas. The company was incorporated in 2012 and is headquartered in Burlington, Massachusetts.
- Sector
- Healthcare
- Industry
- Medical - Specialties
- CEO
- Kevin J. Knopp
- Employees
- 172
- Website
- www.908devices.com
- Address
- 44 3rd Avenue, Burlington, MA, 01803, US
908 Devices (MASS) Earnings & Revenues
MASS Company Deck
MASS Earnings Call
Earnings Call SentimentPositive
The call was broadly positive, supported by record revenue, 35% year-over-year growth, raised guidance, record device shipments, expanding international adoption, strong NIRLab usage and progress toward reduced adjusted EBITDA losses. The company also described multiple growth drivers for 2027, including NIRLab, the next-generation MX908 and AVCAD. Offsetting concerns included a modest adjusted gross margin decline, higher SG&A expenses, continued losses and cash consumption, lower mass spectrometry service revenue, a Q3 decline in state and local revenue, customer concentration and the execution and funding required to reach the upper end of guidance.
View all MASS earnings summariesMASS Stock 12 Month Forecast
Average Price Target
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 7 | 3 | 12 |
| Technical Analysis | 5 | 3 | 2 |
| Moving Averages | 2 | 0 | 10 |














